[Rheumatoid meningitis without arthritis presenting as widespread symmetrical high-intensity lesions along cerebral

Takanobu Kita1, Hiroaki Okada1, Seiji Takenouchi2

  • 1Department of Neurology, Ichinomiya-Nishi Hospital.

Insights

Rheumatoid meningitis, a rare condition, can be diagnosed using anti-cyclic citrullinated peptide antibodies (ACPA) levels, even without arthritis. Testing ACPA and the ACPA index aids diagnosis and treatment monitoring.

Area of Science:

  • Neurology
  • Rheumatology
  • Immunology

Background:

  • Rheumatoid meningitis is an uncommon neurological complication of rheumatoid arthritis.
  • Diagnosis can be challenging, particularly in patients without overt arthritis.
  • Cerebral involvement in rheumatoid arthritis necessitates accurate diagnostic markers.

Purpose of the Study:

  • To investigate the utility of anti-cyclic citrullinated peptide antibodies (ACPA) in diagnosing rheumatoid meningitis.
  • To evaluate the ACPA index in serum and cerebrospinal fluid (CSF) for diagnostic and therapeutic assessment.
  • To highlight a case of rheumatoid meningitis successfully treated with immunotherapy.

Main Methods:

  • Case presentation of a 52-year-old woman with neurological symptoms.
  • Magnetic Resonance Imaging (MRI) with diffusion-weighted imaging (DWI) for neuroimaging.
  • Analysis of serum and CSF for anti-cyclic citrullinated peptide antibodies (ACPA) and calculation of the ACPA index.
  • Brain biopsy for histopathological confirmation.
  • Treatment with high-dose corticosteroids (steroid pulse therapy) and subsequent maintenance therapy.

Main Results:

  • MRI revealed characteristic symmetrical high-intensity lesions in the cerebral hemispheres on DWI.
  • Elevated ACPA levels in serum and CSF, along with an elevated ACPA index, supported the diagnosis.
  • Brain biopsy confirmed inflammatory cell infiltration in the subarachnoid space, indicative of rheumatoid meningitis.
  • The patient achieved full recovery following immunotherapy.

Conclusions:

  • Anti-cyclic citrullinated peptide antibodies (ACPA) testing and ACPA index evaluation are valuable tools for diagnosing rheumatoid meningitis, especially in non-arthritic patients.
  • These immunological markers can aid in assessing therapeutic efficacy.
  • Prompt diagnosis and appropriate treatment, such as steroid pulse therapy, lead to favorable outcomes in rheumatoid meningitis.

Related Concept Videos

Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
199
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
15
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
24
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
15
Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial...
21
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20